Preconception paternal SSRI use linked to ADHD in offspring

Preconception paternal SSRI use linked to ADHD in offspring

(HealthDay)—Paternal use of selective serotonin reuptake inhibitors (SSRIs) before conception is associated with increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a study published online Dec. 11 in Pediatrics.

Fen Yang, from Fudan University in Shanghai, and colleagues conducted a involving 781,470 singletons born between 1996 and 2008 who were followed through 2013. Children whose fathers used SSRIs during the three months preceding conception were identified as exposed.

The researchers found that 0.92 percent of children were born to fathers who had used SSRIs during the three months prior to conception. Overall, 12,520 children were diagnosed with ADHD. After adjustment for potential confounders, exposed children had a 26 percent increased risk of ADHD compared with unexposed (hazard ratio, 1.26; 95 percent confidence interval, 1.06 to 1.51). When extending the exposure window to one year before conception, similarly increased risk of ADHD was seen for paternal use of SSRIs only during the period of 12 to three months before conception and during the last three months before conception (adjusted hazard ratios, 1.35 [95 percent confidence interval, 1.10 to 1.66] and 1.31 [95 percent confidence interval, 0.95 to 1.82]).

"The mildly increased risk of ADHD in offspring associated with paternal SSRI use before could probably be due to the underlying indications related to SSRI use," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: Pediatrics

Copyright © 2017 HealthDay. All rights reserved.

Citation: Preconception paternal SSRI use linked to ADHD in offspring (2017, December 11) retrieved 19 March 2024 from https://medicalxpress.com/news/2017-12-preconception-paternal-ssri-linked-adhd.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Prenatal exposure to ADHD meds tied to neonatal morbidity

0 shares

Feedback to editors